Day: July 27, 2020

WAUSAU, Wis., July 27, 2020 (GLOBE NEWSWIRE) — PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ), the holding company for Peoples State Bank serving North Central and Southeastern Wisconsin, reported second quarter earnings ending June 30, 2020 of $0.72 per share on net income of $3.19 million, compared to earnings of $0.36 per share on net income of $1.61 million during the March 31, 2020 quarter, and $0.57 per share on earnings of $2.57 million during the second quarter a year ago.  Second quarter earnings benefitted from record mortgage refinance income and lower compensation and benefit expenses related to expense deferrals on the origination of Paycheck Protection Program (“PPP”) loans offset in part by higher loan loss provisions and a lower net interest margin. “We are pleased with the success of our operations during the first full...

MCLEAN, Va., July 27, 2020 (GLOBE NEWSWIRE) — Gladstone Investment Corporation (Nasdaq: GAIN) announces the following event:A conference call replay will be available beginning one hour after the call and will be accessible through August 5, 2020. To hear the replay, please dial (855) 859-2056 and use playback conference number 5383517.If you are unable to participate during the live webcast, the call will be archived on the website www.gladstoneinvestment.com. The event will be archived and available for replay on the Company’s website through September 29, 2020.Gladstone Investment Corporation is a publicly traded business development company that seeks to make secured debt and equity investments in lower middle market businesses in the United States in connection with acquisitions, changes in control and recapitalizations.Source:...

ATLANTA, July 27, 2020 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) will host a conference call on Monday, August 10th at 8:30 AM ET to discuss its second quarter 2020 operating results. A press release containing a summary of these results will be issued before the call at approximately 8:00 AM ET.The dial-in number for domestic callers is 877-830-7699. If prompted, the conference ID number is 3379889. Please call five to ten minutes in advance to ensure that you are connected prior to the call.A stream of the call can be accessed via a link at www.cumulusmedia.com/investors. This link can also be used to access a recording of the call following its completion.About CUMULUS MEDIACUMULUS MEDIA is a leading audio-first media and entertainment company delivering premium content to over a quarter billion people every month...

Promising Translational and Clinical Findings Support the Randomized Trial in Newly Diagnosed PatientsNon-Viral Nanoparticle Delivery System, TheraPlas Platform, Demonstrates Potential forLong-Term, Repeat Administration Up To 6 MonthsLAWRENCEVILLE, N.J., July 27, 2020 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), an oncology focused drug-development company, today announced the randomization of the first two patients in the Phase II portion of the Phase I/II OVATION 2 Study with GEN-1 in advanced ovarian cancer. The Company anticipates completing enrollment of up to 118 patients in the third quarter of 2021. Because this is an open-label study, the Company intends to provide clinical updates throughout the course of treatment including response rates and surgical resection scores.GEN-1 was designed using TheraPlas, Celsion’s...

SAN FRANCISCO, July 27, 2020 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE:DLB) will release financial results for the third quarter (Q3) of fiscal 2020 after the close of regular trading on Monday, August 3, 2020.Members of Dolby management will lead a conference call open to all interested parties to discuss Q3 fiscal 2020 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Monday, August 3, 2020.Access to the teleconference will be available over the Internet from http://investor.dolby.com/event-calendar or by dialing 1-800-263-0877. International callers can access the conference call at 1-646-828-8143.A replay of the call will be available from 5:00 p.m. PT on Monday, August 3, 2020, until 8:59 p.m. PT on Monday, August 10, 2020, by dialing 1-844-512-2921 (international callers can access the replay...

FLORHAM PARK, N.J., July 27, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced preclinical data for its COVID-19 vaccine candidate, Versamune-CoV-2 (PDS0203).  PDS0203 pairs the Versamune® platform with a recombinant protein recognized by the human immune system that is derived from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus that causes COVID-19.  The protein included in PDS0203 encompasses SARS-CoV-2 sections that induce an antibody response, as well as sections that are recognized by CD8 and CD4 T-cells.  PDS Biotech has generated robust preclinical data confirming that PDS0203 elicits...

New York, July 27, 2020 (GLOBE NEWSWIRE) — BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) announced that at the Company’s Annual Meeting of Shareholders held on July 24, 2020, its shareholders overwhelmingly voted to approve, in accordance with Nasdaq Marketplace Rule 5635(d), the issuance of shares of the Company’s common stock upon (i) conversion of $4.45 million of senior secured convertible notes sold to two institutional investors (the “Institutional Investors”) on June 2, 2020; (ii) conversion of up to $2.10 million of additional senior secured convertible notes that may be sold to the Institutional Investors; (iii) exercise of up to 1,300,000 warrants issued to the Institutional Investors; and (iv) exercise of warrants to initially purchase 171,845 shares of the Company’s common stock, subject to increase...